SNM Hosts Symposium on Multimodality Cardiovascular Molecular Imaging
March 19, 2009 – The Society of Nuclear Medicine (SNM) will host a two-day symposium Thursday, April 30–Friday, May 1 focused on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair.
The event takes place at the Natcher Auditorium, National Institutes of Health Bethesda, MD. It will bring together individuals from multiple scientific disciplines, including medicine, chemistry, engineering, physics, molecular biology, cardiovascular physiology and imaging sciences. The goal is to build collaboration to share research and promote an advanced understanding of the emerging field of cardiovascular molecular imaging.
SNM and the International Partnership for Critical Markers of Disease (CMOD) will host a satellite meeting devoted to FDA requirements for manufacturing PET radiopharmaceuticals the evening of Friday, May 1. This meeting will take place immediately following the conclusion of the Multimodality Cardiovascular Molecular Imaging Symposium.
This meeting continues the work of an earlier initiative held at the National Institutes of Health, which served as the basis for the first textbook dedicated to the field of cardiovascular molecular imaging. The 2009 meeting is designed to stimulate further growth in the field by attracting individuals from both the basic science and clinical communities, with a special emphasis on encouraging participation by junior scientists. The overall structure of the meeting includes a series of lectures by experts in the field, panel discussions and an abstract poster session.
For more information: www.snm.org/cvmi2009
More like this
- Cardiovascular Nuclear Imaging Advances Highlighted at SNM Symposium
- SNM Cardiovascular Symposium Focuses on Benefits of Imaging Modalities
- SNM Meeting Examines FDA Requirements for Manufacturing PET Radiopharmaceuticals
- Key Late-Breaking Trials to be Presented at TCT 2010
- Molecular Imaging: Molecular Imaging Focuses on Disease Prevention